Silvia La Monica

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

Nicola Giuliani, Simona Colla, Roberto Sala et al. · Blood · 2002 · 266 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells

Mara Bonelli, Graziana Digiacomo, Claudia Fumarola et al. · Neoplasia · 2017 · 105 citations · Full text

Medicine, Oncology, Pharmacology +17

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Daniele Cretella, Andrea Ravelli, Claudia Fumarola et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 105 citations · Full text

Medicine, Oncology, Pharmacology +16

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Silvia La Monica, Daniele Cretella, Mara Bonelli et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 89 citations · Full text

Medicine, Oncology, Pharmacology +16

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones

Andrea Cavazzoni, Mara Bonelli, Claudia Fumarola et al. · Cancer Letters · 2012 · 88 citations

Medicine, Cancer Biology, Oncology +14